(North America, South America, and the Caribbean)
(Including Hong Kong SAR, Macau SAR, and Taiwan)
De novo sequencing is a powerful approach that constructs the complete genomic sequence of an organism without relying on an existing reference genome. This method is particularly valuable for studying species with no prior genomic data, enabling researchers to explore uncharted genetic landscapes. Services can be applied to research of animals, plants, and microorganisms, including phylogenetic studies, analysis of species diversity, genetic markers, and other genomic research.
De novo sequencing is widely used across diverse fields, including:
80Gb - 6Tb output range, 1.6 - 40 B paired end reads per run, and PE150, PE250, PE50, etc.
1.6 – 1.8 Tb output range, 5.3 – 6 B reads per run, and 2 x150 bp max read length.
N50>15kb, 90% of bases ≥Q30, 90Gb HiFi yield / SMRT Cell, 360Gb HiFi yield / run, 24-hour run times etc.
N50>15kb, read lengths up to 25kb (CCS), >99.999% (QV50) consensus accuracy, coverage across high-GC/repeat regions.
Ultra-long reads up to 2Mb, high yields for large genomes, REAL real-time and accessible for flexible budgets.
The field is required.
I agree that Novogene Corporation may use this information to contact me to assist with my request. I understand that all personal information I have submitted will be kept confidential in accordance with Novogene's privacy policy.